Press Releases

Press Releases

Date Title
February 26, 2021
UNITY Biotechnology to Participate in Upcoming March Investor Conferences
SOUTH SAN FRANCISCO, Calif. , Feb. 26, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that members of its senior management team will participate in the following
February 24, 2021
UNITY Biotechnology Reports Granting of New Employment Inducement Awards
SOUTH SAN FRANCISCO, Calif. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that from February 9, 2021 through February 23, 2021 , the Board of
February 8, 2021
Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease
Study shows that senescent cells accumulate in the eye of patients with diabetic retinopathy, and elimination of these cells in preclinical models ameliorates disease Researchers at UNITY Biotechnology and University of Montreal provide mechanistic evidence supporting potential for vascular
February 3, 2021
UNITY Biotechnology Reports Granting of New Employment Inducement Awards
SOUTH SAN FRANCISCO, Calif. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that from January 19, 2021 through February 2, 2021 , the Board of Directors
February 1, 2021
UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor
Mike Sapieha brings world-class expertise in aging-related ophthalmologic and neurologic diseases UNITY also names Jason Damiano , Ph.D., as vice president of translational biology and Nathan Guz , Ph.D., as vice president of operations SOUTH SAN FRANCISCO, Calif. , Feb.